Literature DB >> 10601597

Preoperative evaluation by whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer.

M Mukai1, S Sadahiro, S Yasuda, H Ishida, N Tokunaga, T Tajima, H Makuuchi.   

Abstract

Whole-body positron emission tomography (WB PET) was performed preoperatively in 24 patients with primary colorectal cancer, and the results were compared with the histopathological findings. The PET positive rate was 95.8% (23/24 patients) for the primary tumor. Among nine patients with histologically confirmed lymph node metastasis, two (22.2%) were positive by PET, including one with n1 and one with n4 disease. Among 15 patients without lymph node metastasis histopathologically (n0), two (13.3%) showed false-positive nodes on PET, being diagnosed as n1 and n3 disease, respectively. These results suggest that preoperative PET is useful for the diagnosis of primary colorectal cancer, but it is of limited value for detecting metastasis to the regional lymph nodes surrounding the primary lesion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10601597

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation.

Authors:  Eric Sorenson; Fernando Lambreton; Jian Q Yu; Tianyu Li; Crystal S Denlinger; Joshua E Meyer; Elin R Sigurdson; Jeffrey M Farma
Journal:  J Surg Res       Date:  2019-06-21       Impact factor: 2.192

2.  Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer.

Authors:  H Furukawa; H Ikuma; A Seki; K Yokoe; S Yuen; T Aramaki; S Yamagushi
Journal:  Gut       Date:  2005-12-16       Impact factor: 23.059

Review 3.  Restaging of colorectal cancer and PET/CT.

Authors:  Alev Çınar; Esra Arzu Gençoğlu; Meliha Korkmaz
Journal:  Ulus Cerrahi Derg       Date:  2013-06-01

4.  FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.

Authors:  Anthony T Ruys; Roel J Bennink; Henderik L van Westreenen; Marc R Engelbrecht; Olivier R Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2011-03-07       Impact factor: 3.647

5.  [PET/CT for colorectal and hepatic tumors].

Authors:  J Stollfuss; H Wieder; E Rummeny; M Schwaiger
Journal:  Radiologe       Date:  2004-11       Impact factor: 0.635

6.  Pre-operative TNM staging of primary colorectal cancer by (18)F-FDG PET-CT or PET: a meta-analysis including 2283 patients.

Authors:  Yanwei Ye; Tao Liu; Lisha Lu; Guojun Wang; Min Wang; Jingjing Li; Chao Han; Jianguo Wen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

7.  Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer.

Authors:  Jose Manuel Llamas-Elvira; Antonio Rodríguez-Fernández; Javier Gutiérrez-Sáinz; Manuel Gomez-Rio; María Bellon-Guardia; Carlos Ramos-Font; Angel Custodio Rebollo-Aguirre; Dolores Cabello-García; Antonio Ferrón-Orihuela
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-29       Impact factor: 10.057

8.  The Use of PET-CT in the Assessment of Patients with Colorectal Carcinoma.

Authors:  Owen J O'Connor; Shanaugh McDermott; James Slattery; Dushyant Sahani; Michael A Blake
Journal:  Int J Surg Oncol       Date:  2011-07-03

Review 9.  Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options.

Authors:  P A Georgiou; P P Tekkis; G Brown
Journal:  Cancer Imaging       Date:  2011-10-03       Impact factor: 3.909

Review 10.  PET/CT in oncology: for which tumours is it the reference standard?

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.